These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2939951)

  • 41. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.
    Dellsperger KC; Martins JB; Clothier JL; Marcus ML
    Circulation; 1990 Sep; 82(3):941-50. PubMed ID: 1975521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The progression from hypertrophy to heart failure.
    Tarazi RC
    Hosp Pract (Off Ed); 1983 Aug; 18(8):101-7, 111-4, 119-22. PubMed ID: 6223873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.
    Motz W; Strauer BE
    Clin Investig; 1992; 70 Suppl 1():S87-92. PubMed ID: 1534267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy.
    Tubau JF; Szlachcic J; Braun S; Massie BM
    Hypertension; 1989 Jul; 14(1):1-8. PubMed ID: 2525526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
    Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
    J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of antihypertensive treatment on cardiac hypertrophy and cardiac function in elderly hypertensive patients.
    Nagano N; Iwatsubo H; Hata T; Mikami H; Ogihara T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S163-5. PubMed ID: 1715472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pump performance after regression of cardiac hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; de Almeida JB; Amorim MP; Portela J; Cezaretti ML; Ramos OL
    J Hypertens Suppl; 1989 Dec; 7(6):S288-9. PubMed ID: 2534415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
    Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and natural history of electrocardiographic left ventricular hypertrophy.
    Kannel WB
    Am J Med; 1983 Sep; 75(3A):4-11. PubMed ID: 6226193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of hypertrophy of the left ventricle on myocardial perfusion in patients with arterial hypertension].
    Gurgenian SV; Mikaelian RS; Mikaelian ES; Oganesian AN
    Kardiologiia; 1988 Sep; 28(9):70-4. PubMed ID: 2976854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive drug therapy and regression of left ventricular hypertrophy: a review with a focus on diuretics.
    Moser M; Setaro JF
    Eur Heart J; 1991 Sep; 12(9):1034-9. PubMed ID: 1834464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
    Tarazi RC; Frohlich ED
    Circulation; 1987 Jan; 75(1 Pt 2):I113-7. PubMed ID: 2947744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Considerations in treating hypertension: focus on risk factors.
    Messerli FH
    J Hum Hypertens; 1990 Dec; 4 Suppl 5():3-6. PubMed ID: 2151045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Left ventricular hypertrophy: an independent factor of risk.
    Frohlich ED
    Cardiovasc Clin; 1990; 20(3):85-94. PubMed ID: 2140072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.
    McLenachan JM; Henderson E; Morris KI; Dargie HJ
    N Engl J Med; 1987 Sep; 317(13):787-92. PubMed ID: 2957590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.